NeuroSense Therapeutics Statistics
Total Valuation
NRSN has a market cap or net worth of $26.59 million. The enterprise value is $26.95 million.
Important Dates
The last earnings date was Wednesday, December 18, 2024.
Earnings Date | Dec 18, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NRSN has 23.13 million shares outstanding. The number of shares has increased by 42.04% in one year.
Current Share Class | 23.13M |
Shares Outstanding | 23.13M |
Shares Change (YoY) | +42.04% |
Shares Change (QoQ) | +5.88% |
Owned by Insiders (%) | 41.33% |
Owned by Institutions (%) | 1.14% |
Float | 13.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21
Current Ratio | 0.21 |
Quick Ratio | 0.20 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.17 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -219.64% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$644,222 |
Employee Count | 18 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.50% in the last 52 weeks. The beta is 1.36, so NRSN's price volatility has been higher than the market average.
Beta (5Y) | 1.36 |
52-Week Price Change | +46.50% |
50-Day Moving Average | 1.15 |
200-Day Moving Average | 1.15 |
Relative Strength Index (RSI) | 50.31 |
Average Volume (20 Days) | 496,121 |
Short Selling Information
The latest short interest is 290,561, so 1.26% of the outstanding shares have been sold short.
Short Interest | 290,561 |
Short Previous Month | 324,354 |
Short % of Shares Out | 1.26% |
Short % of Float | 2.14% |
Short Ratio (days to cover) | 2.01 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -11.19M |
Pretax Income | -10.11M |
Net Income | -11.60M |
EBITDA | -11.17M |
EBIT | -11.19M |
Earnings Per Share (EPS) | -$0.66 |
Full Income Statement Balance Sheet
The company has $344,000 in cash and $19,000 in debt, giving a net cash position of $325,000 or $0.01 per share.
Cash & Cash Equivalents | 344,000 |
Total Debt | 19,000 |
Net Cash | 325,000 |
Net Cash Per Share | $0.01 |
Equity (Book Value) | -2.82M |
Book Value Per Share | -0.14 |
Working Capital | -3.00M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |